Cargando…

Cali cancer registry methods

BACKGROUND: The Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali. METHODS: The collection of new cancer cases in permanent residents of Cali is done through active searc...

Descripción completa

Detalles Bibliográficos
Autores principales: García, Luz Stella, Bravo, Luis Eduardo, Collazos, Paola, Ramírez, Oscar, Carrascal, Edwin, Nuñez, Marcela, Portilla, Nelson, Millan, Erquinovaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad del Valle 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018820/
https://www.ncbi.nlm.nih.gov/pubmed/29983471
http://dx.doi.org/10.25100/cm.v49i1.3853
Descripción
Sumario:BACKGROUND: The Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali. METHODS: The collection of new cancer cases in permanent residents of Cali is done through active search in and notification from hospitals, and public and private laboratories. The Secretary of Municipal Public Health provides individual information on general mortality and death from cancer. Tumors are coded with ICDO-3 and mortality with ICD-10. Presented rates are standardized by age and trends are assessed by estimating the percentage annual change using the regression analysis in JoinPoint. The 5-year net survival was analyzed with the Pohar-Perme estimator. RESULTS: The 88.5% of the registered cancers had morphological verification (MV). The proportion of unknown primary site represented 5% and the death certificate only cases (DCO) varied between 0 to3% depending on the cancer site. All deaths were certified by a physician, 94.2% of cancer deaths were correctly certified. The ill-defined site proportion was 5.3% and that of uterine cancer not specified (C55) was 0.5%. For survival analysis, existing data collection procedure and infrastructure ensures assessment of the patient’s vital status and follow-up, with an average lost to follow-up of 13.2%. COMMENT: The information has been published in the eleven volumes of "Cancer Incidence in Five Continents" confirming high quality of the collected data. The RPCC PCRC has also participated in the Concord Study and is participating in SURVCAN-3.